Adagene (ADAG) Total Current Liabilities (2019 - 2025)

Adagene's (ADAG) quarterly Total Current Liabilities came in at $25172.1 billion in Q4 2025, down 34.08% year-on-year from $38184.9 billion in Q4 2024, and up 88272715.97% on a QoQ basis from $28.5 million in Q2 2025.

Adagene (ADAG) Total Current Liabilities (2019 - 2025) Analysis & Trends

Adagene (ADAG) has 7 years of Total Current Liabilities data on file, last reported at $25172.1 billion in Q4 2025.

  • On a quarterly basis, Total Current Liabilities fell 34.08% year-over-year to $25172.1 billion in Q4 2025; TTM through Dec 2025 was $25172.1 billion, a 34.08% decrease from a year earlier, with the FY2025 full-year figure at $25172.1 billion, down 34.08% from the prior year.
  • Total Current Liabilities for Q4 2025 stood at $25172.1 billion, up from $28.5 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for ADAG reached as high as $56455.1 billion in Q2 2022 and fell as low as $28.5 million in Q2 2025.
  • Historically, Total Current Liabilities has averaged $24534.0 billion across 5 years, with a median of $28313.9 billion in 2023.
  • Across the five-year window, Total Current Liabilities jumped 190877015.16% in 2022 and tumbled 100.0% in 2024, its largest moves.
  • Year by year, Total Current Liabilities stood at $29.8 million in 2021, then soared by 184697642.74% to $55080.4 billion in 2022, then slumped by 42.89% to $31455.6 billion in 2023, then advanced by 21.39% to $38184.9 billion in 2024, then tumbled by 34.08% to $25172.1 billion in 2025.
  • Per Business Quant data, the three most recent Total Current Liabilities figures were $25172.1 billion in Q4 2025, $28.5 million in Q2 2025, and $38184.9 billion in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 56.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 66.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.81 Bn
4 NuCana 279.75 Bn 279.75 Bn - 6.38 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 289.60 Mn
10 Adagene 198.85 Mn 198.85 Mn - 25,172.10 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 25,172.10 Bn
Jun 30, 2025 28.52 Mn
Dec 31, 2024 38,184.94 Bn
Jun 30, 2024 39.52 Mn
Dec 31, 2023 31,455.65 Bn
Jun 30, 2023 38,991.62 Bn
Dec 31, 2022 55,080.40 Bn
Jun 30, 2022 56,455.10 Bn
Dec 31, 2021 29.82 Mn
Jun 30, 2021 29.58 Mn
Dec 31, 2020 16.15 Mn
Dec 31, 2019 7.18 Mn